XIIlab Co.,Ltd (KOSDAQ: 189330)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,150.00
+50.00 (0.70%)
Oct 11, 2024, 9:00 AM KST

XIIlab Co.,Ltd Statistics

Total Valuation

XIIlab Co.,Ltd has a market cap or net worth of KRW 42.65 billion. The enterprise value is 34.46 billion.

Market Cap 42.65B
Enterprise Value 34.46B

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date Nov 13, 2024
Ex-Dividend Date n/a

Share Statistics

XIIlab Co.,Ltd has 6.09 million shares outstanding. The number of shares has increased by 0.73% in one year.

Shares Outstanding 6.09M
Shares Change (YoY) +0.73%
Shares Change (QoQ) n/a
Owned by Insiders (%) 47.30%
Owned by Institutions (%) n/a
Float 3.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.47
PB Ratio 3.86
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.88
EV / Sales 6.04
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -5.75

Financial Position

The company has a current ratio of 7.27, with a Debt / Equity ratio of 0.12.

Current Ratio 7.27
Quick Ratio 6.91
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF -0.23
Interest Coverage -74.24

Financial Efficiency

Return on equity (ROE) is -48.20% and return on invested capital (ROIC) is -27.80%.

Return on Equity (ROE) -48.20%
Return on Assets (ROA) -25.63%
Return on Capital (ROIC) -27.80%
Revenue Per Employee 75.09M
Profits Per Employee -92.98M
Employee Count 76
Asset Turnover 0.32
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -46.56% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -46.56%
50-Day Moving Average 7,305.80
200-Day Moving Average 10,419.30
Relative Strength Index (RSI) 48.47
Average Volume (20 Days) 180,358

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, XIIlab Co.,Ltd had revenue of KRW 5.71 billion and -7.07 billion in losses. Loss per share was -1,160.30.

Revenue 5.71B
Gross Profit 281.44M
Operating Income -7.26B
Pretax Income -7.07B
Net Income -7.07B
EBITDA -6.05B
EBIT -7.26B
Loss Per Share -1,160.30
Full Income Statement

Balance Sheet

The company has 9.56 billion in cash and 1.36 billion in debt, giving a net cash position of 8.19 billion or 1,344.42 per share.

Cash & Cash Equivalents 9.56B
Total Debt 1.36B
Net Cash 8.19B
Net Cash Per Share 1,344.42
Equity (Book Value) 11.06B
Book Value Per Share 1,815.41
Working Capital 8.86B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.62 billion and capital expenditures -372.80 million, giving a free cash flow of -5.99 billion.

Operating Cash Flow -5.62B
Capital Expenditures -372.80M
Free Cash Flow -5.99B
FCF Per Share -983.95
Full Cash Flow Statement

Margins

Gross margin is 4.93%, with operating and profit margins of -127.14% and -123.82%.

Gross Margin 4.93%
Operating Margin -127.14%
Pretax Margin -123.82%
Profit Margin -123.82%
EBITDA Margin -106.02%
EBIT Margin -127.14%
FCF Margin -105.04%

Dividends & Yields

XIIlab Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.73%
Shareholder Yield -0.73%
Earnings Yield -16.58%
FCF Yield -14.06%

Stock Splits

The last stock split was on September 15, 2021. It was a forward split with a ratio of 2.

Last Split Date Sep 15, 2021
Split Type Forward
Split Ratio 2

Scores

XIIlab Co.,Ltd has an Altman Z-Score of 13.55.

Altman Z-Score 13.55
Piotroski F-Score n/a